Mithramycin A
-
- Applikation
- Inhibition (Inh)
- Verwendungszweck
- Transcription inhibitor, Inhibits DNA methyltransferase
- Produktmerkmale
- Inhibits DNA methyl transferase. A selective Sp1 inhibitor, it binds to GC rich DNA sequences, displacing Sp1 transcription factor binding to oncogene promoters, inhibitings their expression. Mithramycin A (at 10-200 nM) sensitizes tumor cells to TRAIL-induced apoptosis.
- Reinheit
- >98 %
- Formel
- C52H76O24
- Löslichkeit
- Soluble in DMSO (up to 20 mg/ml) or in Ethanol (up to 10 mg/ml).
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Powder
- Vorsichtsmaßnahmen
-
GHS – Classification
Acute toxicity, Oral (Category 4), H302 - Lagerung
- -20 °C
-
- Hintergrund
- A2371, Antibiotic LA 7017, Aureolic Acid, NSC 24559, PA 144, Plicamycin,Epigenetics,Chromatin,DNA methyltransferase,RNA,Antibiotic,Cell death,Infectious disease,Apoptosis inducer,Transcription
- Molekulargewicht
- 1085.15
- CAS-Nummer
- 18378-89-7
-